Various analytical charts can now be searched on each product detail page and Product Document Search.
(The kinds of analytical charts differ by product. We will continue to add charts that are currently unavailable.)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 242478-38-2 | Product Number: S0944
Solifenacin Succinate
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 25MG |
₩76,800
|
≥20 | 10 |
| 100MG |
₩224,000
|
11 | 16 |
* Please contact our distributor of SEJIN CI
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination.
* SEJIN CI (Phone: 02-2655-2480 / email: sales@sejinci.co.kr)
* SEJIN CI (Phone: 02-2655-2480 / email: sales@sejinci.co.kr)
| Product Number | S0944 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__3H__2__6N__2O__2·C__4H__6O__4 = 480.56 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 242478-38-2 |
| Related CAS RN | 242478-37-1 |
| PubChem Substance ID | 253662487 |
| Merck Index (14) | 8712 |
| MDL Number | MFCD09952287 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 %(total of Ion-Pair) |
| Melting point | 145.0 to 149.0 °C |
Properties (reference)
| Melting Point | 147 °C |
| Solubility in water | Completely soluble |
| Solubility (very soluble in) | Methanol |
| Solubility (slightly sol. in) | Ethanol |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | NW7136000 |
Transport Information:
| H.S.code* | 2933.99-000 |
Application
Solifenacin Succinate: Selective M3 Muscarinic Receptor Antagonist
Solifenacin succinate is a selective M3 muscarinic receptor antagonist. It is used for the treatment of overactive bladder (OAB). For your reference, [P2215] is a key synthetic intermediate of solifenacin succinate. (The product is for research purpose only.)
References
- M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland
- In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats
- Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells
- Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists
- Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents
PubMed Literature
Articles/Brochures
TCIMAIL
Documents
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number
Incorrect Lot Number is entered
The requested Analytical Chart is not available.